Mark Clements

Learn More
Eosinophilic meningitis is rare in Hodgkin's disease. Five previous cases have been reported. We describe an additional patient whose CSF showed an eosinophilic pleocytosis with Reed-Sternberg cells while in complete systemic remission from Hodgkin's disease. The patient responded to intrathecal administration of methotrexate given by Ommaya reservoir. Six(More)
BACKGROUND The excess risks of death from any cause and death from cardiovascular causes among persons with type 2 diabetes and various levels of glycemic control and renal complications are unknown. In this registry-based study, we assessed these risks according to glycemic control and renal complications among persons with type 2 diabetes. METHODS We(More)
BACKGROUND Diabetes is an established risk factor for heart failure, but because nearly all heart failure occurs in older individuals, the excess risk and risk factors for heart failure in individuals with type 1 diabetes are not known. We aimed to determine the excess risk of heart failure in individuals with type 1 diabetes overall and by different levels(More)
A voided urine specimen from a 29-year-old male living in New York was sent for cytologic study, which revealed five schistosome ova, two with terminal spines, and one free miracidium in a cytocentrifuge specimen. The patient, who had been in West Africa three years earlier, underwent cystoscopy, with the finding of bladder mucosal ulcerations. Subsequent(More)
Four separate renal neoplasms were removed from a 64-year-old man during a period of 8 months. A lesion was first identified in the left kidney and the nephrectomy specimen had 2 separate adenocarcinomas. A third adenocarcinoma and a papillary urothelial pelvic carcinoma were found subsequently and segmentally resected from the right kidney. The patient(More)
AIM This study examined long-term effects of continuous subcutaneous insulin infusion (CSII) in clinical practice on glycemic control in patients with type 1 diabetes. SUBJECTS AND METHODS We evaluated all type 1 diabetes patients at 10 diabetes outpatient clinics in Sweden who had been treated with CSII for at least 5.5 years and had valid glycated(More)
Careful medical and laboratory monitoring of 27 subjects during a 28-day use of a 330-calorie (Cal)/day liquid formula, with weight loss averaging 9.1 kg (range, 3.2 to 19.1 kg), included a 22-factor automated blood chemistry analysis, BP, hematology, urine analysis, lipid profile, delayed cutaneous hypersensitivity, differential cell count, ECG, and Holter(More)
BACKGROUND Multicenter long-term studies of predictors for the effectiveness of continuous subcutaneous insulin infusion (CSII) in clinical practice are lacking. We hypothesized that there are substantially greater reductions in hemoglobin A1c (HbA1c) in patients with poor glycemic control and that other predictors may also exist. SUBJECTS AND METHODS We(More)
  • 1